Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

3-(2-(5-bromo-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-4,5,6,7-tetrahydro-1H-indol-3-yl)propionic acid MeSH Supplementary Concept Data 2025


MeSH Supplementary
3-(2-(5-bromo-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-4,5,6,7-tetrahydro-1H-indol-3-yl)propionic acid
Unique ID
C411456
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C411456
Entry Term(s)
3-BODTIPA
Registry Numbers
0
Heading Mapped to
*Indoles
*Propionates
Frequency
1
Note
inhibits VEGF-R2, FGF-R1, and PDGF-Rbeta; structure in first source
Source
J Med Chem 2000 Jul 13;43(14):2655-63
Indexing Information
Receptors, Growth Factor
Receptor Protein-Tyrosine Kinases
Date of Entry
2000/08/01
Revision Date
2012/08/20
3-(2-(5-bromo-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-4,5,6,7-tetrahydro-1H-indol-3-yl)propionic acid Preferred
page delivered in 0.007s